Adhesion molecules and their role in vascular disease

American Journal of Hypertension

Volumn 14, Issue 6 II, 2001, Pages

  Krieglstein, Christian F ^a,b   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Endothelial cells; Hypertension; Inflammation; Ischemia reperfusion; Microcirculation

Indexed keywords

CELL ADHESION MOLECULE; GLYCOPROTEIN; INTEGRIN; SELECTIN;

CARDIOVASCULAR DISEASE; CELL INTERACTION; CONFERENCE PAPER; DIABETES MELLITUS; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034987955     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02069-6     Document Type: Conference Paper

References (111)

1. Modulation of calcium current in arteriolar smooth muscle by vβ3 and 5β1 integrin ligands
2. Molecular mechanisms that control endothelial cell contacts
3. Ischemia-reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease
4. Selectins
5. Circulating adhesion molecules in disease
6. GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium
7. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation
8. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide
9. Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions
10. Expression of a protective intestinal immune response can be inhibited at three distinct sites by treatment with anti-alpha 4 integrin
11. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1
12. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium
13. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
14. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3
15. Leukocyte-endothelial adhesion molecules
16. The beta 7 integrins in mucosal homing and retention
17. Purified intercellular adhesion molecule 1 (ICAM-1) is a ligand for lymphocyte function-associated antigen (LFA-1)
18. 7
19. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
20. + subunit induces recognition of the RGDS sequence in fibronectin
21. 1 (VLA-5) integrins
22. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
23. Adhesion receptors of the immune system
24. Identification of an inducible endothelial-leukocyte adhesion molecule
25. A natural adherence molecule (ICAM-1): Induction by IL-1 and IFN-, tissue distribution, biochemistry, and function
26. Regional differences in constitutive and induced ICAM-1 expression in vivo
27. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse
28. A form of circulating ICAM-1 in human serum
29. Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in human malignancies
30. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
31. The expression of human intercellular adhesion molecule 2 is refractory to inflammatory cytokines
32. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule
33. Molecular and functional aspects of PECAM-1/CD31
34. A tissue-specific endothelial cell molecule involved in leukocyte homing
35. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion
36. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins
37. Significance of lipid mediators in shock states
38. Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta
39. Function and activation of NF-κB in the immune system
40. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers
41. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription
42. Postischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice
43. Cellular and molecular mechanisms of endothelial cell dysfunction
44. Neutrophil enhancement of reperfusion-induced capillary fluid filtration associated with hypercholesterolemia
45. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage
46. Ischemia/reperfusion-induced microvascular dysfunction: Role of oxidants and lipid mediators
47. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster
48. Leukocyte-endothelial cell interactions evoked by mast cells
49. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion
50. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells
51. Modulation of P-selectin expression in the post-ischemic intestinal microvasculature
52. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats
53. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats
54. Oxidative stress in the Dahl hypertensive rat
55. Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats
56. Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats
57. Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats
58. Increased severity of acute myocardial ischemia in experimental atherosclerosis
59. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion
60. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans
61. Superoxide and peroxynitrite in atherosclerosis
62. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice
63. Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholesterolemic rats
64. Diabetes exacerbates the inflammatory responses to ischemia-reperfusion
65. Mechanisms responsible for enhanced inflammatory response to ischemia-reperfusion in diabetes
66. Reperfusion-induced oxidative stress in diabetes: Cellular and enzymatic sources
67. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin dependent diabetes mellitus
68. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid
69. Coagulation studies in ulcerative colitis and Crohn's disease
70. Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats
71. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis
72. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
73. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
74. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques
75. Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3
76. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
77. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
78. Cellular adhesion molecules and atherogenesis
79. Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney
80. Cell adhesion molecules and the glomerulopathies
81. The role of cell adhesion molecules in ischemic acute renal failure
82. Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells
83. A role for P selectin in complement-independent neutrophil-mediated glomerular injury
84. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis
85. Expression of leucocyte and lymphocyte adhesion molecules in the human kidney
86. Expression of VCAM-1 in the normal and diseased kidney
87. Leukocyte adhesion molecules and kidney diseases
88. Interactions between T lymphocytes and endothelial cells in allograft rejection
89. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients
90. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1
91. Cellular adhesion molecules. Newly identified mediators of angiogenesis
92. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts
93. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells
94. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury
95. Role of CD1 la and CD11b in ischemic acute renal failure in rats
96. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand
97. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients
98. Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection
99. Immunologic aspects of vasculitis and cardiovascular disease
100. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis
101. Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis
102. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
103. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa
104. Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis
105. Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: Inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions
106. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis
107. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited
108. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: Marked differences between Wegener's granulomatosis and systemic lupus erythematosus
109. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus
110. Circulating soluble adhesion molecules in systemic vasculitis
111. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1